Free Trial

Zentek (CVE:ZEN) Shares Cross Above 50 Day Moving Average - Time to Sell?

Zentek logo with Medical background

Shares of Zentek Ltd. (CVE:ZEN - Get Free Report) passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$1.36 and traded as high as C$1.41. Zentek shares last traded at C$1.41, with a volume of 71,202 shares changing hands.

Zentek Stock Performance

The stock has a fifty day moving average price of C$1.37 and a 200-day moving average price of C$1.28. The company has a current ratio of 2.20, a quick ratio of 7.59 and a debt-to-equity ratio of 5.91. The firm has a market capitalization of C$146.71 million, a price-to-earnings ratio of -11.75 and a beta of 0.77.

About Zentek

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

Recommended Stories

→ Stunning Trump Exec Order Leaked (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Zentek right now?

Before you consider Zentek, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.

While Zentek currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Future of Healthcare: 3 AI Stocks Leading the Way
Analysts Predict Big Gains for These 3 Cybersecurity Leaders
This Investment Strategy Has the Highest Payout Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines